Role of hematopoietic growth factors/flt3 ligand in expansion and regulation of dendritic cells

Current Opinion in Hematology

Volumn 8, Issue 3, 2001, Pages 149-154

  McKenna, Hilary J ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; VACCINE;

ANTIGEN PRESENTING CELL; CELL ACTIVATION; CELL MATURATION; DENDRITIC CELL; HEMATOPOIETIC CELL; HUMAN; IMMUNE RESPONSE; LYMPH NODE; PRIORITY JOURNAL; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; CELL CULTURE TECHNIQUES; DENDRITIC CELLS; HEMATOPOIESIS; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; LIGANDS; MEMBRANE PROTEINS;

EID: 0035047535     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200105000-00004     Document Type: Review

References (57)

1. The dendritic cell system and its role in immunogenicity
2. Immunobiology of dendritic cells
3. Cross-presentation: A general mechanism for CTL immunity and tolerance
4. Dendritic cells in cancer immunotherapy
5. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
6. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: A comparative analysis with Flt3 ligand
7. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs
8. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures
9. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
10. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
11. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells
12. Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells
13. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors
14. DC-SIGN-ICAM-2 interaction mediates dendritic cells trafficking
15. Signals required for differentiating dendritic cells from human monocytes in vitro
16. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use
17. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo
18. In vivo generation of human dendritic cell subsets by Flt3 ligand
19. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
20. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
21. Reciprocal control of T helper cell and dendritic cell differentiation
22. Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio
23. Monocyte-derived CD1a+ and CD1a-dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation
24. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction
25. Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients
26. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients
27. Developmental control of endocytosis in dendritic cells by Cdc42
28. The role of aquaporins in dendritic cell macropinocytosis
29. Transport of peptide-MHC class II complexes in developing dendritic cells
30. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10
31. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
32. The role of chemokine receptors in primary, effector, and memory immune responses
33. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation
34. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes
35. CpG motifs induce Langerhans cell migration in vivo
36. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
37. Ligation of CD40 on dendritic cells triggers production of high levels of intedeukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
38. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells
39. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment [In Process Citation]
40. CD40 Triggering of Heterodimeric IL-12 p70 Production by Dendritic Cells In Vivo Requires a Microbial Priming Signal
41. IL-4 is a mediator of IL-12p70 induction by human Th2 cells: Reversal of polarized Th2 phenotype by dendritic cells
42. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells
43. A critical role for interleukin 4 in activating alloreactive CD4 T cells
44. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells
45. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors
46. Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells
47. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines
48. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
49. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
50. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo
51. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
52. Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice
53. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene
54. Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization
55. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
56. Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity
57. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma